EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of a Lassa Fever Specimen Biobank in Nigeria

Hanesh F Chi, Johnson Etafo, Fritz Fonkeng, Gbenga-Ayeni Bosede Olufunke, Ronke Ireneh, Chukwuyem Abejegah, Sampson Owhin, Stella Somiari, Aurélia Vessière, Daniel G Bausch, Imane El Idrissi, Warren Fransman und 4 weitere

The American Journal of Tropical Medicine and Hygiene · 2025

DOI: 10.4269/ajtmh.24-0527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Hanesh F Chi und 15 weiteren Autor:innen. Beteiligte Einrichtung: FIND, Geneva, Switzerland. Hauptthemen laut MEDLINE: Lassa Fever, Biological Specimen Banks, Lassa virus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite being a dangerous disease found across West Africa, with occasional cases imported elsewhere, few medical countermeasures for Lassa fever are available, with no vaccine or validated treatment, and limited regulatory-approved diagnostics. Scientific research on the Lassa virus (LASV) is needed to accelerate the development of such tools but is dependent on access to high-quality biological samples. To meet this need, we have established a well-curated biobank to prospectively collect, process, and store high-quality, well-characterized clinical specimens from patients with Lassa fever at the Federal Medical Center Owo (FMCO) in Nigeria. Patients presenting to FMCO with symptoms of Lassa fever were tested for LASV by polymerase chain reaction and screened for eligibility. Samples of whole blood, plasma, and serum were collected at baseline, and at 4- and 8-weeks post-baseline from LASV-positive (LASV+) participants. Of 197 participants enrolled, 99 were LASV+ and 98 LASV-negative. In total, 3,599 sample aliquots were stored, comprised of 264 whole blood, 1,572 serum, and 1,763 plasma samples. The Lassa fever biobank now provides support for scientific research, including the evaluation of diagnostics and biomarkers, as well as the development and validation of other medical countermeasures for the detection, prevention, and control of Lassa fever. Processes for accessing samples are described.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lassa FeverBiological Specimen BanksLassa virusHumansNigeriaFemaleMaleAdultMiddle AgedSpecimen HandlingAdolescentYoung AdultChildProspective StudiesAged

Autor:innen und Institutionen

  • FIND, Geneva, Switzerland.
  • Federal Medical Centre Owo, Owo, Nigeria.
  • ITSI Biosciences, Johnstown, Pennsylvania.
  • London School of Hygiene and Tropical Medicine, London, United Kingdom.

Zitieren

APA

Chi, H. F., Etafo, J., Fonkeng, F., Olufunke, G. B., Ireneh, R., Abejegah, C., Owhin, S., Somiari, S., Vessière, A., Bausch, D. G., El Idrissi, I., Fransman, W., Kelly-Cirino, C., Agogo, E., Emperador, D. M., & Adedosu, N. A. (2025). Establishment of a Lassa Fever Specimen Biobank in Nigeria. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.24-0527

Vancouver

Chi HF, Etafo J, Fonkeng F, Olufunke GB, Ireneh R, Abejegah C, et al. Establishment of a Lassa Fever Specimen Biobank in Nigeria. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.24-0527

BibTeX
@article{Chi2025,
  author = {Chi, Hanesh F and Etafo, Johnson and Fonkeng, Fritz and Olufunke, Gbenga-Ayeni Bosede and Ireneh, Ronke and Abejegah, Chukwuyem and Owhin, Sampson and Somiari, Stella and Vessière, Aurélia and Bausch, Daniel G and El Idrissi, Imane and Fransman, Warren and Kelly-Cirino, Cassandra and Agogo, Emmanuel and Emperador, Devy M and Adedosu, Nelson A},
  title = {Establishment of a Lassa Fever Specimen Biobank in Nigeria},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2025},
  doi = {10.4269/ajtmh.24-0527}
}
Kostenlos starten →